New Zealand at a glance
- Population
- 5.3 million 2025
- Life expectancy at birth
- 82.0 years, 2024
- People aged 65 and over
- 17.6 % of people, 2025
- Health spending per person
- 5,022 US$ per person, 2024
- Doctors
- 3.61 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
New Zealand Skin Boosters Market Industry Trends and Forecast to 2034: Segmented by (Product, Area, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$19.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $9.3 Mn | — | — |
| 2025 (base) | $10.5 Mn | +$1.2 Mn | — |
| 2026 (forecast) | $11.8 Mn | +$1.3 Mn | +12.4% |
| 2027 (forecast) | $13.2 Mn | +$1.5 Mn | +26.3% |
| 2028 (forecast) | $14.9 Mn | +$1.6 Mn | +42% |
| 2029 (forecast) | $16.7 Mn | +$1.8 Mn | +59.6% |
| 2030 (forecast) | $18.8 Mn | +$2.1 Mn | +79.4% |
| 2031 (forecast) | $21.1 Mn | +$2.3 Mn | +101.6% |
| 2032 (forecast) | $23.8 Mn | +$2.6 Mn | +126.7% |
| 2033 (forecast) | $26.7 Mn | +$2.9 Mn | +154.8% |
| 2034 (forecast) | $30.0 Mn | +$3.3 Mn | +186.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $10.5 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $30.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, area and end user (see all) |
| Key players | Galderma S.A., Allergan, Teoxane, Croma Pharma, Mastelli (see all) |
| Regulator in New Zealand | MedsafeSource: Medsafe. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Skin boosters are injectable treatments, often hyaluronic acid, that hydrate and improve skin quality rather than add volume.
Key segments of the skin Boosters market include product (Hyaluronic Acid Boosters, Polynucleotides and Exosome Boosters) and area (Face, Neck and Hands).
Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the skin Boosters market. More clinics and chains are opening in fast-growing cities.
Treatments for men, at-home options, digital consultations and growth in Asia and the Middle East give the skin Boosters market room to grow.
Treatments are mostly paid out of pocket, results and safety vary between providers, and economic slowdowns can reduce spending on the skin Boosters market.
The skin Boosters market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medsafe, part of the Ministry of Health, approves medicines before they can be sold.[1] Pharmac decides which medicines and medical devices the public health system pays for.[2]
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for skin Boosters. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.
What doctors and scientists are doing in Skin Boosters right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.
From our blog
New Zealand
New Zealand
New Zealand
New Zealand
New Zealand
New Zealand
Medical Devices · New Zealand
Medical Devices · New Zealand
Digital Health · New Zealand
Healthcare Services · New Zealand
OTC & Nutraceuticals · New Zealand
OTC & Nutraceuticals · New Zealand